Brie Carter

Capricorn Metals (ASX:CMM) announced it is on track to meet the upper tier of its FY26 production guidance.

NorthStrive Defense Tech (NASDAQ:ELAB) has moved to bolster its maritime and littoral combat portfolio, announcing it has secured an exclusive option to license a specialized multi-domain drone system under U.S. Patent No. 12,291,334.

Energy Minister Chris Bowen has confirmed that Australia’s liquid fuel security is bolstered "well into" May.

The AFL and NRL are preparing for a financial hit as the Albanese government unveils a sweeping suite of gambling advertising reforms.

Jet.AI (NASDAQ:JTAI), a developer of artificial intelligence-driven software for the private aviation industry, has announced a 1-for-200 reverse stock split effective before the market opens on April 8, 2026.

Amgen (NASDAQ:AMGN) has announced positive topline results from its Phase 3 clinical trial evaluating a subcutaneous formulation of TEPEZZA (teprotumumab-trbw) for adults with moderate-to-severe active Thyroid Eye Disease (TED).

Inspira Technologies (NASDAQ:IINN) has reached a definitive agreement to acquire the Additive Manufacturing Electronics (AME) platform from Nano Dimension, marking a significant expansion of its technical capabilities and intellectual property portfolio.

Bitcoin climbed to a session high of $70,275 on 6 April, restoring its market capitalisation above $1.4 trillion.

Neurocrine Biosciences (NASDAQ:NBIX) announced today a definitive agreement to acquire Soleno for $53 per share in an all-cash transaction valued at approximately $2.9 billion, significantly broadening its commercial portfolio in the rare disease and endocrinology sectors.

Profusa (NASDAQ:PFSA) has entered into a non-binding letter of intent to acquire the PanOmics multi-omics diagnostics platform from BioInsights, a move that shifts the commercial-stage digital health company into the high-growth molecular diagnostics market.